Inhibrx Biosciences, Inc. (INBX) stock
Close on Nov 13, 2026Market cap $1.23BP/E –Yield –
Inhibrx Biosciences statistics
67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 18, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 1.01%
- 10.8%
- Shares Change (QoQ)
- 0.34%
- 0.50%
- Float
- 10M
- 49M
- Shares Held by Insiders
- 35.4%
- 11.7%
- Shares Held by Institutions
- 97.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- -0.82%
- -0.80%
- Short % of Float
- 35.7%
- 9.01%
- Short % of Shares Outstanding
- 23.0%
- 6.30%
- Days to Cover
- 10.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $155.29
- –
- 52-Week Low
- $57.30
- –
- 20-Day Moving Average
- $86.28
- –
- 50-Day Moving Average
- $95.27
- –
- 200-Day Moving Average
- $92.69
- –
- Average True Range (14)
- $6.80
- –
- Price Change (1 Week)
- -1.44%
- -1.15%
- Price Change (1 Month)
- -7.96%
- -4.87%
- Price Change (3 Months)
- -9.47%
- -21.0%
- Price Change (6 Months)
- -23.3%
- -20.6%
- Price Change (YTD)
- 5.44%
- -23.6%
- Price Change (1 Year)
- 13.6%
- -22.4%
- Price Change (3 Years)
- 312.0%
- -29.5%
- Price Change (5 Years)
- 92.6%
- -77.9%
- Average Volume (10 Days)
- 241,157
- –
- Average Volume (20 Days)
- 303,291
- –
- Average Volume (90 Days)
- 283,134
- –
- Relative Volume
- 0.85
- 0.70
- Relative Strength Index (14)
- 45.1
- 43.4
- Volatility (1 Year)
- 82.1%
- 80.1%
- Beta (5 Years)
- 1.70
- 1.07
Returns on capitalIndustry
- Return on Assets (ROA)
- -71.2%
- -40.6%
- Return on Capital Employed (ROCE)
- -65.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 7.58
- 3.30
- Quick Ratio
- 7.31
- 2.39
- Interest Coverage
- -5.95
- -6.35
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -16.0%
- 2.25%
- Revenue Growth (5Y CAGR)
- -36.8%
- 6.41%
EfficiencyIndustry
- Profits Per Employee
- -$1.29M
- -$689.41K
- Employee Count
- 110
- 74
- WACC
- 12.2%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$141.66M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$77.23M
- $17.76M
- Net Cash Per Share
- -$5.25
- $0.80
- Equity (Book Value)
- -$85.88M
- $53.89M
- Book Value Per Share
- -$5.83
- $1.50
- Tangible Book Value
- -$85.88M
- $27.13M
- Working Capital
- $179.57M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$29.00K
- -$1.00M
- FCF Per Share
- -$9.02
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -11.6%
- -21.8%
- FCF Yield
- -10.8%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $21.14M
- $2.90M
- Income Tax
- $3.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.76
- 0.23
- Piotroski F-Score
- 1
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | INBX | S&P 500 | Difference | INBX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.3% | -3.0% | −1.3 pts | ||
| 3 months | -14.1% | -2.8% | −11.4 pts | ||
| Year to date | +5.4% | +11.5% | −6.0 pts | ||
| 1 year | +11.6% | +13.5% | −1.8 pts | ||
| 3 years | +323.1% | +77.7% | +245.4 pts | +61.7% | +21.1% |
| 5 years | +92.6% | +72.6% | +20.0 pts | +14.0% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M INBX shares were sold short on Oct 30, 2026, down 0.8% from the previous report, or 35.66% of the shares available to trade. At recent volumes it would take 10.0 days to buy them back. Over the last 20 sessions, 66.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,389,154 | -0.8% | 339,064 | 10.0 |
| Oct 15, 2026 | 3,417,073 | -0.5% | 202,984 | 16.8 |
| Sep 30, 2026 | 3,432,642 | +1.2% | 290,359 | 11.8 |
| Sep 15, 2026 | 3,393,511 | +2.9% | 408,480 | 8.3 |
| Aug 31, 2026 | 3,297,743 | +2.6% | 317,496 | 10.4 |
| Aug 14, 2026 | 3,215,230 | -3.8% | 223,490 | 14.4 |
| Jul 31, 2026 | 3,341,210 | -2.7% | 213,594 | 15.6 |
| Jul 15, 2026 | 3,433,872 | -0.4% | 379,873 | 9.0 |
| Jun 30, 2026 | 3,447,032 | +4.5% | 347,713 | 9.9 |
| Jun 15, 2026 | 3,299,693 | +3.8% | 321,930 | 10.3 |
| May 29, 2026 | 3,179,335 | +8.4% | 341,252 | 9.3 |
| May 15, 2026 | 2,932,658 | +7.3% | 654,241 | 4.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?